Memorial Sloan Kettering MSK

New York, New York 10065

0 studies enrolling now · 2 studies all time

What they study most

Multiple Myeloma, Tumors Characterized by Genetic Abnormalities of ALK

Studies at this site

• A Study of CLN-619 (Anti-MICA/MICB Antibody) in Patients With Relapsed and Refractory Multiple Myeloma — Running, not enrolling
• A Dose Escalation/Expansion Study of LDK378 in Patients With Tumors Characterized by Genetic Abnormalities in Anaplastic Lymphoma Kinase — Completed